Stock screenerAll disclosures →
EDGAR →
CTNM
Conviction 79HealthcareScan · Mon, Aug 10, 2026Three outside down
CTNM$14.48-3.72%
ResistanceSupportVol 14Insider sell2
Vol MA14 334.82K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price14.48
Change-3.72%
Gap-1.40%
Rel volume4.52×
Avg volume291.9K
Avg $ vol4.33M
SMA 2014.68
SMA 5013.86
SMA 20013.01
Price vs 50+4.51%
Price vs 200+11.29%
MA stackbullish
50/200 cross—
Supertrendup · 12.52
RSI (14)48
MACD hist-0.04
MACD crossbear · 0d
Stoch %K / %D35 / 49
ADX (14)17
+DI / −DI17 / 16
RSI divergence—
MACD divergence—
ATR %+7.48%
ADR %7.09%
52w high16.39
52w low6.43
From 52w high-11.65%
Above 52w low+125.19%
New 52w highNo
SqueezeOn · 8d
Bollinger width19.20%
%B0.43
Donchian pos35.47%
Donchian high16.70
Donchian low13.26
AVWAP (52w high)15.04
vs AVWAP high-3.71%
AVWAP (52w low)12.85
vs AVWAP low+12.65%
OBV trendDown
Chaikin MF (20)-0.04
Today vs 20d4.52×
Avg vol (14d)334.82K
Avg vol (20d)291.9K
Avg $ vol (20d)4.33M
Market cap—
RS 3m (vs SPY)-2.89%
RS 6m (vs SPY)-10.25%
RS line new highNo
Trend template7/8
Technical rank47.7
1 week-9.10%
1 month-4.67%
3 months-0.34%
6 months-3.47%
1 year+115.16%
YTD+27.13%
P/E-5.80
P/B1.45
P/S—
P/FCF-6.26
EPS-2.17
Div yield—
ROE-25.03%
ROA-23.96%
Debt/Eq—
Current37.17
EV/EBITDA-4.92
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-41.93%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value333.16M
Revenue0
Net income-15.15M
Gross profit—
Free cash flow-55.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.72M
Employees51
ListedFri, Apr 5, 2024
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction79 / 100
Pattern quality—
Tech rank47.7 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmThree outside down
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CTNM
No recent disclosed trades by Congress in CTNM. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CTNM · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-07-09 | Sell | 25 | $400 | 2026-07-09 | 2026-07-10 |
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-07-09 | Exercise | 25 | $25 | 2026-07-09 | 2026-07-10 |
Lorrain Daniel S. Chief Scientific Officer · Stock Option (right to buy) · 2026-07-09 | Exercise | 25 | — | 2026-07-09 | 2026-07-10 |
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-07-08 | Sell | 1.01K | $16K | 2026-07-08 | 2026-07-10 |
Lorrain Daniel S. Chief Scientific Officer · Class A Common Stock · 2026-07-08 | Exercise | 1.01K | $1K | 2026-07-08 | 2026-07-10 |
Lorrain Daniel S. Chief Scientific Officer · Stock Option (right to buy) · 2026-07-08 | Exercise | 1.01K | — | 2026-07-08 | 2026-07-10 |
Stengone Carmine N. CEO and President · Class A Common Stock · 2026-07-08 | Exercise | 2.5K | $3K | 2026-07-08 | 2026-07-08 |
Stengone Carmine N. CEO and President · Class A Common Stock · 2026-07-08 | Sell | 2.5K | $40K | 2026-07-08 | 2026-07-08 |
Stengone Carmine N. CEO and President · Stock Option (right to buy) · 2026-07-08 | Exercise | 2.5K | — | 2026-07-08 | 2026-07-08 |
Schimmelpennink Evert B. Director · Stock Option (right to buy) · 2026-06-26 | Grant | 19K | — | 2026-06-26 | 2026-06-26 |
SEC filings
EDGAR filings in CTNM · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.